Skip to content

Clinical trials

Phase 4 Fibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Phase: Phase 4 Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20051
20072
20081
20121
20134
20141
20152
20163
20171
20182
20202
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated4
Unknown status3
Withdrawn1
Recruiting1
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
Bausch Health Americas, Inc.2
Intercept Pharmaceuticals2
Weill Medical College of Cornell University2
Beth Israel Deaconess Medical Center1
Center For Hepatitis C, Atlanta, GA1
Icahn School of Medicine at Mount Sinai1
Mercy Medical Center1
Nguyen Thi Trieu, MD1
Soonchunhyang University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis26
Hepatitis C7
Ascites4
Hepatitis C, Chronic4
Liver Diseases4
Anemia, Hemolytic3
Hemolysis3
Brain Diseases2
Carcinoma, Hepatocellular2
Hepatic Encephalopathy2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.